Accuracy, Safety, and Workflow of Frameless Neuronavigation-Guided Stereoelectroencephalography in Drug-Resistant Epilepsy: A Single-Center Cohort Study

BACKGROUND AND OBJECTIVES: Stereoelectroencephalography (SEEG) is central to invasive presurgical evaluation in drug-resistant epilepsy (DRE). We evaluated the accuracy, safety, and workflow efficiency of frameless neuronavigation-guided SEEG in routine clinical practice. METHODS: This retrospective single-center cohort included consecutive adult and pediatric patients with DRE who underwent SEEG between July 2016 and August 2025. Entry-point and target-point deviations were measured on postoperative computed tomography fused to the preoperative planning data set. Safety end points were perioperative complications. Operative duration and time per electrode were recorded. Comparative analyses between AdTech and Dixi systems were restricted to the primary-surgery cohort to maintain independent samples. A subgroup analysis examined procedures performed by experienced surgeons, defined as more than 250 implanted electrodes. RESULTS: Seventy-seven patients underwent 82 SEEG procedures. Across all procedures, 984 electrodes were implanted. The median number of electrodes per surgery was 13. The median entry-point and target-point deviations were 2.1 and 1.8 mm, respectively. Entry-point deviation did not differ between AdTech and Dixi electrodes in the primary-surgery cohort (2.1 vs 2.1 mm; P = .579), whereas target-point deviation was slightly lower with Dixi (1.6 vs 1.9 mm; P = .030). The duration of Dixi procedures was shorter than AdTech procedures (102 vs 186 minutes P < .001) and had lower time per electrode (10 vs 14 minutes; P < .001). Four minor hemorrhagic complications occurred (4.9%/procedure; 0.4%/electrode); no permanent neurological deficits, reoperations, hardware-related complications, or procedure-related deaths occurred. A seizure-onset zone was localized in 48 patients (62%), enabling subsequent resective or disconnective surgery. CONCLUSION: Frameless neuronavigation-guided SEEG achieved reproducible millimetric accuracy, low morbidity, and efficient workflow in a consecutive real-world cohort. These findings support frameless neuronavigation as a safe and scalable option for invasive presurgical evaluation in DRE.

Authors

Institutions

Publication Details

Journal
Operative Neurosurgery
Published
2026-10-28
DOI
https://doi.org/10.1227/ons.0000000000002228
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Accuracy, Safety, and Workflow of Frameless Neuronavigation-Guided Stereoelectroencephalography in Drug-Resistant Epilepsy: A Single-Center Cohort Study

Gudrun Gröppel, Katharina Wach, Gabriela Azevedo Sansoni, Sharon Samueli et al.
2 links
Operative Neurosurgery
Epilepsy research and treatment
article

Accuracy, Safety, and Workflow of Frameless Neuronavigation-Guided Stereoelectroencephalography in Drug-Resistant Epilepsy: A Single-Center Cohort Study

Gudrun Gröppel, Katharina Wach, Gabriela Azevedo Sansoni, Sharon Samueli, Christian Auer, Tobias Rossmann, Andreas Gruber, Thomas Hauser, Birgit Stark, Katharina Knogler
article en

Abstract

BACKGROUND AND OBJECTIVES: Stereoelectroencephalography (SEEG) is central to invasive presurgical evaluation in drug-resistant epilepsy (DRE). We evaluated the accuracy, safety, and workflow efficiency of frameless neuronavigation-guided SEEG in routine clinical practice. METHODS: This retrospective single-center cohort included consecutive adult and pediatric patients with DRE who underwent SEEG between July 2016 and August 2025. Entry-point and target-point deviations were measured on postoperative computed tomography fused to the preoperative planning data set. Safety end points were perioperative complications. Operative duration and time per electrode were recorded. Comparative analyses between AdTech and Dixi systems were restricted to the primary-surgery cohort to maintain independent samples. A subgroup analysis examined procedures performed by experienced surgeons, defined as more than 250 implanted electrodes. RESULTS: Seventy-seven patients underwent 82 SEEG procedures. Across all procedures, 984 electrodes were implanted. The median number of electrodes per surgery was 13. The median entry-point and target-point deviations were 2.1 and 1.8 mm, respectively. Entry-point deviation did not differ between AdTech and Dixi electrodes in the primary-surgery cohort (2.1 vs 2.1 mm; P = .579), whereas target-point deviation was slightly lower with Dixi (1.6 vs 1.9 mm; P = .030). The duration of Dixi procedures was shorter than AdTech procedures (102 vs 186 minutes P < .001) and had lower time per electrode (10 vs 14 minutes; P < .001). Four minor hemorrhagic complications occurred (4.9%/procedure; 0.4%/electrode); no permanent neurological deficits, reoperations, hardware-related complications, or procedure-related deaths occurred. A seizure-onset zone was localized in 48 patients (62%), enabling subsequent resective or disconnective surgery. CONCLUSION: Frameless neuronavigation-guided SEEG achieved reproducible millimetric accuracy, low morbidity, and efficient workflow in a consecutive real-world cohort. These findings support frameless neuronavigation as a safe and scalable option for invasive presurgical evaluation in DRE.

Operative Neurosurgery
Johannes Kepler University of Linz (AT), Kepler Universitätsklinikum (AT)
Good health and well-being
Openalex Percentile: Top 12%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon